Status:
ACTIVE_NOT_RECRUITING
Theory-based Health Behaviour Change Intervention in Patients of Metabolic Syndrome With Chronic Kidney Disease
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Chronic Kidney Diseases
Metabolic Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pilot study will adopt a 2-arm, pretest-posttest, and assessor-blind randomized controlled trial design to examine the feasibility and acceptability of a theory-based health behaviour change inter...
Detailed Description
Metabolic syndrome (MetS) is a worldwide chronic disease mainly due to unhealthy diets and sedentary lifestyles. According to the International Diabetes Federation (IDF) definition of MetS, patients m...
Eligibility Criteria
Inclusion
- Participants are 18 years old and above;
- Participants have both diagnoses of MetS based on IDF clinical diagnostic criteria (WC for Chinese: ≥ 90 cm in men and ≥ 80 cm in women, and fulfils two items of the following: TG ≥ 1.7 mmol/L or treatment for hypertriglycerides, HDL-C\<1.03 mmol/L in men or \<1.29 mmol/L in women or treatment for low HDL-C, FG ≥5.6 mmol/L or previously diagnosed type 2 diabetes, and BP ≥ 130/85 mmHg or treatment for hypertension). and CKD (eGFR \< 60 mL/min/1.73 m2 or a UACR ≥ 30 mg/g for at least three months);
- No medical contraindications to exercise, including walking;
- Participants are capable of understanding and providing informed consent;
- Own a smartphone for accessing WeChat;
- Being able to communicate in Chinese;
- Stay in Chengdu during the study period.
Exclusion
- Participants who cannot perform brisk walking exercise;
- Participants who have already started dialysis or kidney transplant;
- Current participation in another clinical trial related to health behaviour change or medical trial;
- Participants who have doctor-diagnosed psychiatric illness;
- Participants who have a cognitive impairment, which will be screened by the abbreviated mental test with a score lower than seven;
- Adjustment of medication within half a year;
- Participants who have performed regular planned exercise (Defined as at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of high-intensity aerobic activity per week, or a combination of moderate-intensity and high-intensity aerobic activity) within the past month.
Key Trial Info
Start Date :
July 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06527768
Start Date
July 31 2024
End Date
May 30 2026
Last Update
December 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital of Sichuan University
Chengdu, Sichuan, China, 610000